<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="102036-2018" EDITION="2018046"><TECHNICAL_SECTION><RECEPTION_ID>18-102266-001</RECEPTION_ID><DELETION_DATE>20180613</DELETION_DATE><FORM_LG_LIST>IT </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>46</NO_OJ><DATE_PUB>20180307</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 046-102036</NO_DOC_OJS><URI_LIST><URI_DOC LG="IT">http://ted.europa.eu/udl?uri=TED:NOTICE:102036-2018:TEXT:IT:HTML</URI_DOC></URI_LIST><LG_ORIG>IT</LG_ORIG><ISO_COUNTRY VALUE="IT"/><IA_URL_GENERAL>http://www.asst-santipaolocarlo.it</IA_URL_GENERAL><ORIGINAL_CPV CODE="33652100">Antineoplastic agents</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="ITC4C">Milano</n2016:PERFORMANCE_NUTS><VALUES_LIST><VALUES TYPE="GLOBAL"><SINGLE_VALUE><VALUE CURRENCY="EUR">1 671 150,00</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">1 671 150,00</VALUE></SINGLE_VALUE></VALUES></VALUES_LIST></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180305</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="3">Regional or local authority</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="V">Contract award without prior publication</PR_PROC><RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Итaлия</TI_CY><TI_TOWN>Милано</TI_TOWN><TI_TEXT>Антинеопластични средства</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Itálie</TI_CY><TI_TOWN>Milán</TI_TOWN><TI_TEXT>Antineoplastika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Italien</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Cytostatika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Italien</TI_CY><TI_TOWN>Mailand</TI_TOWN><TI_TEXT>Antineoplastische Mittel</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ιταλία</TI_CY><TI_TOWN>Μιλάνο</TI_TOWN><TI_TEXT>Αντινεοπλασματικά φάρμακα</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Italy</TI_CY><TI_TOWN>Milan</TI_TOWN><TI_TEXT>Antineoplastic agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Italia</TI_CY><TI_TOWN>Milán</TI_TOWN><TI_TEXT>Agentes antineoplásicos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Itaalia</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Antineoplastilised ained</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Italia</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Solunsalpaajat ja sytostaatit</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Italie</TI_CY><TI_TOWN>Milan</TI_TOWN><TI_TEXT>Antinéoplasiques</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Iodáil, an</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Antineoplastic agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Italija</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Antineoplastični lijekovi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Olaszország</TI_CY><TI_TOWN>Milánó</TI_TOWN><TI_TEXT>Daganatellenes szerek</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Italia</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Agenti antineoplastici</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Italija</TI_CY><TI_TOWN>Milanas</TI_TOWN><TI_TEXT>Antinavikiniai vaistai</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Itāija</TI_CY><TI_TOWN>Milāna</TI_TOWN><TI_TEXT>Antineoplastiskie līdzekļi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>l-Italja</TI_CY><TI_TOWN>Milan</TI_TOWN><TI_TEXT>Aġenti ta' l-antineoplastika</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Italië</TI_CY><TI_TOWN>Milaan</TI_TOWN><TI_TEXT>Antineoplastische middelen</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Włochy</TI_CY><TI_TOWN>Mediolan</TI_TOWN><TI_TEXT>Środki przeciwnowotworowe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Itália</TI_CY><TI_TOWN>Milão</TI_TOWN><TI_TEXT>Antineoplásicos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Italia</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Antineoplazice</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Taliansko</TI_CY><TI_TOWN>Miláno</TI_TOWN><TI_TEXT>Antineoplastické činidlá</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Italija</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Zdravila z delovanjem na novotvorbe</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Italien</TI_CY><TI_TOWN>Milano</TI_TOWN><TI_TEXT>Cytostatika/cytotoxiska medel</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="IT">Azienda Socio-Sanitaria Territoriale (ASST) Santi Paolo e Carlo</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="IT" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Azienda Socio-Sanitaria Territoriale (ASST) Santi Paolo e Carlo</OFFICIALNAME></ORGANISATION><ADDRESS>Via Antonio di Rudinì 8</ADDRESS><TOWN>Milano</TOWN><POSTAL_CODE>20142</POSTAL_CODE><COUNTRY VALUE="IT"/><CONTACT_POINT>S.C. Provveditorato</CONTACT_POINT><ATTENTION>Ufficio Acquisizione Beni di Consumo</ATTENTION><PHONE>+39 0281842120</PHONE><E_MAILS><E_MAIL>ufficiogare.hsp@asst-santipaolocarlo.it</E_MAIL></E_MAILS><FAX>+39 0281844000</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD><URL_GENERAL>http://www.asst-santipaolocarlo.it</URL_GENERAL><URL_BUYER>http://www.asst-santipaolocarlo.it</URL_BUYER></INTERNET_ADDRESSES_CONTRACT_AWARD></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="REGIONAL_AUTHORITY"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES><PURCHASING_ON_BEHALF><PURCHASING_ON_BEHALF_NO/></PURCHASING_ON_BEHALF></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>Procedura negoziata senza previa pubblicazione di un bando, mediante sistema di intermediazione telematica «Sintel», per l’affidamento della fornitura, in esclusiva, della specialità medicinale «Keytruda (principio attivo: «Pembrolizumab») 100 mg» occorrente all'ASST Santi Paolo e Carlo di Milano.  </P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/><TYPE_SUPPLIES_CONTRACT VALUE="PURCHASE"/></TYPE_CONTRACT_LOCATION_W_PUB><LOCATION_NUTS><LOCATION><P>Magazzino S.C. Farmacia del Presidio «San Paolo», Via A. di Rudinì 8, Milano, e del Presidio «San Carlo», Via Pio II 3, Milano</P></LOCATION><n2016:NUTS CODE="ITC4C"/></LOCATION_NUTS><SHORT_CONTRACT_DESCRIPTION><P>Fornitura, in esclusiva, della specialità medicinale «Keytruda (principio attivo: «Pembrolizumab») 100 mg» occorrente all'ASST Santi Paolo e Carlo di Milano.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33652100"/></CPV_MAIN></CPV><CONTRACT_COVERED_GPA VALUE="YES"/></DESCRIPTION_AWARD_NOTICE_INFORMATION><TOTAL_FINAL_VALUE><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="1671150.00">1 671 150,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></TOTAL_FINAL_VALUE></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><F03_AWARD_WITHOUT_PRIOR_PUBLICATION><ANNEX_D><NO_MANUFACTURED_BY_DIRECTIVE/><JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><REASONS_PROVIDED_PARTICULAR_TENDERER><REASONS_PROVIDED_PARTICULAR_TENDERER_TECHNICAL/><REASONS_PROVIDED_PARTICULAR_TENDERER_EXCLUSIVE_RIGHTS/></REASONS_PROVIDED_PARTICULAR_TENDERER><NO_EXTREME_URGENCY_EVENTS_UNFORESEEABLE/><NO_ADDITIONAL_WORKS/><NO_SUPPLIES_QUOTED_PURCHASED_COMMODITY_MARKET/></JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><NO_ONLY_IRREGULAR_INACCEPTABLE_TENDERERS/><REASON_CONTRACT_LAWFUL/></ANNEX_D></F03_AWARD_WITHOUT_PRIOR_PUBLICATION></TYPE_OF_PROCEDURE_DEF><AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><AWARD_CRITERIA_DETAIL_F03><LOWEST_PRICE/></AWARD_CRITERIA_DETAIL_F03><F03_IS_ELECTRONIC_AUCTION_USABLE VALUE="NO"/></AWARD_CRITERIA_CONTRACT_AWARD_NOTICE_INFORMATION><ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD><FILE_REFERENCE_NUMBER><P>Deliberazione n. 1856/2017</P></FILE_REFERENCE_NUMBER><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3><NO_PREVIOUS_PUBLICATION_EXISTS_F3/></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3></ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_NUMBER>1</CONTRACT_NUMBER><LOT_NUMBER>1</LOT_NUMBER><CONTRACT_TITLE><P>Fornitura, in esclusiva, della specialità medicinale «Keytruda (principio attivo: «Pembrolizumab») 100 mg» occorrente all'ASST Santi Paolo e Carlo di Milano.</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>03</DAY><MONTH>11</MONTH><YEAR>2017</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><OFFERS_RECEIVED_NUMBER_MEANING>1</OFFERS_RECEIVED_NUMBER_MEANING><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>MSD Italia S.r.l.</OFFICIALNAME></ORGANISATION><ADDRESS>Via Vitorchiano 151</ADDRESS><TOWN>Roma</TOWN><POSTAL_CODE>00189</POSTAL_CODE><COUNTRY VALUE="IT"/><E_MAILS><E_MAIL>ufficiogare.msd@pec.it</E_MAIL></E_MAILS><PHONE>+39 06361911</PHONE><FAX>+39 0633225277</FAX></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT CURRENCY="EUR"><VALUE_COST FMTVAL="1671150.00">1 671 150,00</VALUE_COST><EXCLUDING_VAT/></INITIAL_ESTIMATED_TOTAL_VALUE_CONTRACT><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="1671150.00">1 671 150,00</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE><MORE_INFORMATION_IF_ANNUAL_MONTHLY><NUMBER_OF_MONTHS>6</NUMBER_OF_MONTHS></MORE_INFORMATION_IF_ANNUAL_MONTHLY></CONTRACT_VALUE_INFORMATION><MORE_INFORMATION_TO_SUB_CONTRACTED><NO_CONTRACT_LIKELY_SUB_CONTRACTED/></MORE_INFORMATION_TO_SUB_CONTRACTED></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><RELATES_TO_EU_PROJECT_NO/><ADDITIONAL_INFORMATION><P>Il CIG è: 7197521E36. Durata del contratto: sei mesi. Il responsabile unico del procedimento è il dott. Francesco Graffi — Responsabile S.C.Provveditorato</P></ADDITIONAL_INFORMATION><PROCEDURES_FOR_APPEAL><APPEAL_PROCEDURE_BODY_RESPONSIBLE><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Tribunale Amministrativo Regionale per la Lombardia</OFFICIALNAME></ORGANISATION><ADDRESS>Via Corridoni 39</ADDRESS><TOWN>Milano (MI)</TOWN><POSTAL_CODE>20122</POSTAL_CODE><COUNTRY VALUE="IT"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></APPEAL_PROCEDURE_BODY_RESPONSIBLE><LODGING_OF_APPEALS><LODGING_OF_APPEALS_PRECISION><P>Contro il presente provvedimento è proponibile ricorso al Tribunale Amministrativo Regionale per la Lombardia entro 30 giorni dalla piena conoscenza.</P></LODGING_OF_APPEALS_PRECISION></LODGING_OF_APPEALS></PROCEDURES_FOR_APPEAL><NOTICE_DISPATCH_DATE><DAY>05</DAY><MONTH>03</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>